80 related articles for article (PubMed ID: 15781191)
1. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
[TBL] [Abstract][Full Text] [Related]
2. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
[TBL] [Abstract][Full Text] [Related]
3. Exploratory Untargeted Metabolomics of Dried Blood Spot Samples from Newborns with Maple Syrup Urine Disease.
Alotaibi AZ; AlMalki RH; Al Mogren M; Sebaa R; Alanazi M; Jacob M; Alodaib A; Alfares A; Abdel Rahman AM
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891907
[TBL] [Abstract][Full Text] [Related]
4. Melatonin improves behavioral parameters and oxidative stress in zebrafish submitted to a leucine-induced MSUD protocol.
Duarte MB; Medeiros BZ; da Silva Lemos I; da Silva GL; Alano CG; Dondossola ER; Torres CA; Effting PS; Rico EP; Streck EL
Metab Brain Dis; 2023 Aug; 38(6):2105-2114. PubMed ID: 37099078
[TBL] [Abstract][Full Text] [Related]
5. Computational structural genomics and clinical evidence suggest BCKDK gain-of-function may cause a potentially asymptomatic maple syrup urine disease phenotype.
Singh E; Chi YI; Kopesky J; Zimmerman M; Urrutia R; Basel D; Schwoerer JS
JIMD Rep; 2024 May; 65(3):144-155. PubMed ID: 38736638
[TBL] [Abstract][Full Text] [Related]
6. Memantine Improves Memory and Neurochemical Damage in a Model of Maple Syrup Urine Disease.
Lemos IDS; Torres CA; Alano CG; Matiola RT; de Figueiredo Seldenreich R; Padilha APZ; De Pieri E; Effting PS; Machado-De-Ávila RA; Réus GZ; Leipnitz G; Streck EL
Neurochem Res; 2024 Mar; 49(3):758-770. PubMed ID: 38104040
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the management of patients with maple syrup urine disease diagnosed by newborn screening in a developing country.
De Castro-Hamoy LG; Chiong MA; Estrada SC; Cordero CP
J Community Genet; 2017 Jan; 8(1):9-15. PubMed ID: 27714667
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Branched Amino Acids by UPLC as an Alternative Method for the Management of Patients with MUSD.
Nasrallah F; Hadj-Taieb S; Sanhaji H; Kaabachi N; Feki M
Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084699
[TBL] [Abstract][Full Text] [Related]
9. The interplay of psychosis and non-compliance with fatal outcome in an adult with MSUD.
Falah N; Pendyal S; Sasannejad C; Gibson A; Lee YL; McDonald M; Koeberl D
Am J Med Genet A; 2024 Apr; ():e63637. PubMed ID: 38682838
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen during gestation prevents some changes in physical and reflex development in offspring in a model of hyperleucinemia and maternal inflammation.
de Franceschi ID; da Silva JD; Nitzke Minuzzi B; de Barros KC; Fernandes EK; Bortoluzzi VT; Rieger E; Preissler T; Feksa LR; Hahn RZ; Linden R; Rech VC; Casali EA; Wannmacher CMD
Int J Dev Neurosci; 2020 Aug; 80(5):369-379. PubMed ID: 32379904
[TBL] [Abstract][Full Text] [Related]
11. Real-world management of maple syrup urine disease (MSUD) metabolic decompensations with branched chain amino acid-free formulas in France and Germany: A retrospective observational study.
de Lonlay P; Posset R; Mütze U; Mention K; Lamireau D; Schiff M; Servais A; Arnoux JB; Brassier A; Dao M; Douillard C; Ottolenghi C; Pontoizeau C; Miotto F; Le Mouhaër J
JIMD Rep; 2021 May; 59(1):110-119. PubMed ID: 33977036
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 11 years of newborn screening for maple syrup urine disease in the Netherlands and a systematic review of the literature: Strategies for optimization.
Stroek K; Boelen A; Bouva MJ; De Sain-van der Velden M; Schielen PCJI; Maase R; Engel H; Jakobs B; Kluijtmans LAJ; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; Visser G; de Vries MC; Williams M; Heijboer AC; Kemper EA; Bosch AM
JIMD Rep; 2020 Jul; 54(1):68-78. PubMed ID: 32685353
[TBL] [Abstract][Full Text] [Related]
13. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
[TBL] [Abstract][Full Text] [Related]
14. Classical maple syrup urine disease and brain development: principles of management and formula design.
Strauss KA; Wardley B; Robinson D; Hendrickson C; Rider NL; Puffenberger EG; Shellmer D; Moser AB; Morton DH
Mol Genet Metab; 2010 Apr; 99(4):333-45. PubMed ID: 20061171
[TBL] [Abstract][Full Text] [Related]
15. Social outcome in adults with maple syrup urine disease (MSUD).
Simon E; Schwarz M; Wendel U
J Inherit Metab Dis; 2007 Apr; 30(2):264. PubMed ID: 17310329
[TBL] [Abstract][Full Text] [Related]
16. Implications of Maple Syrup Urine Disease in Newborns.
Harris-Haman P; Brown L; Massey S; Ramamoorthy S
Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
[TBL] [Abstract][Full Text] [Related]
17. [Maple Syrup Urine Disease in a newborn infant].
Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
